Literature DB >> 24964693

Guidelines for health technology assessment in Thailand (second edition)--the development process.

Usa Chaikledkaew, Kankamon Kittrongsiri.   

Abstract

The first Thai-specific HTA guidelines were completed in 2008 with the aim of ensuring that all HTA data was accurate, of high quality, and relevant for making decisions pertaining to healthcare resource allocation. Based on a quality assessment of 89 economic evaluation studies in the Thai context published in international academic journals between 1982 and 2012, the analysis revealed a significant increase in quality of data sources and result reporting in studies published after the dissemination of the first Thai HTA guidelines. As the first Thai HTA guidelines were developed in 2008, a number of areas for improvement have been identified. Therefore, the objective of this chapter is to describe the development process of this second edition of HTA guidelines for Thailand which builds on the success of the first edition, while attempting to address some of the identified limitations of the first edition and reflect the changes that the health care and policy contexts have undergone in the intervening years. It is hoped that this second edition will continue to build on these successes so that policy decision making becomes increasingly evidence-based.

Entities:  

Mesh:

Year:  2014        PMID: 24964693

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  14 in total

1.  Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand.

Authors:  Krittimeth Trerayapiwat; Peerawat Jinatongthai; Prin Vathesatogkit; Piyamitr Sritara; Ninutcha Paengsai; Piyameth Dilokthornsakul; Surakit Nathisuwan; Lan My Le; Nathorn Chaiyakunapruk
Journal:  Lancet Reg Health West Pac       Date:  2022-06-24

2.  Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand.

Authors:  Pochamana Phisalprapa; Ratthanon Prasitwarachot; Chayanis Kositamongkol; Pranaidej Hengswat; Weerachai Srivanichakorn; Chaiwat Washirasaksiri; Sombat Treeprasertsuk; Phunchai Charatcharoenwitthaya; Nathorn Chaiyakunapruk
Journal:  BMC Gastroenterol       Date:  2021-03-25       Impact factor: 3.067

Review 3.  National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison.

Authors:  Deepshikha Sharma; Arun Kumar Aggarwal; Laura E Downey; Shankar Prinja
Journal:  Pharmacoecon Open       Date:  2021-01-10

4.  Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand.

Authors:  Ithiphon Viratanapanu; Chavalit Romyen; Komol Chaivanijchaya; Sikarin Sornphiphatphong; Worawit Kattipatanapong; Ajjana Techagumpuch; Krit Kitisin; Suppa-Ut Pungpapong; Chadin Tharavej; Patpong Navicharern; Patchaya Boonchayaanant; Suthep Udomsawaengsup
Journal:  J Obes       Date:  2019-02-03

5.  EQ-5D-5L population norms and health inequalities for Trinidad and Tobago.

Authors:  Henry Bailey; Mathieu F Janssen; Althea La Foucade; Paul Kind
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

6.  Efficacy and economic evaluation of delivery of care with tele-continuous EEG in critically ill patients: a multicentre, randomised controlled trial (Tele-cRCT) study protocol.

Authors:  Chusak Limotai; Atiporn Ingsathit; Kunlawat Thadanipon; Oraluck Pattanaprateep; Anuchate Pattanateepapon; Kammant Phanthumchinda; Nijasri C Suwanwela; Iyavut Thaipisuttikul; Kanokwan Boonyapisit; Ammarin Thakkinstian
Journal:  BMJ Open       Date:  2020-03-04       Impact factor: 2.692

7.  The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes
Journal:  Clinicoecon Outcomes Res       Date:  2017-07-17

8.  Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand.

Authors:  Nitichen Kittiratchakool; Disorn Kulpokin; Chonticha Chanjam; Soamarat Vilaiyuk; Sirirat Charuvanij; Gun Phongsamart; Parichat Khaosut; Manasita Tanya; Ratanavadee Nanagara; Sira Nantapaisarn; Pattara Leelahavarong
Journal:  BMJ Open       Date:  2020-09-15       Impact factor: 2.692

9.  Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.

Authors:  Viroj Tangcharoensathien; Walaiporn Patcharanarumol; Waraporn Suwanwela; Somruethai Supangul; Warisa Panichkriangkrai; Hathairat Kosiyaporn; Woranan Witthayapipopsakul
Journal:  Int J Health Policy Manag       Date:  2020-04-01

10.  Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines.

Authors:  Chris Painter; Wanrudee Isaranuwatchai; Juthamas Prawjaeng; Hwee Lin Wee; Brandon Wen Bing Chua; Vinh Anh Huynh; Jing Lou; Fang Ting Goh; Nantasit Luangasanatip; Wirichada Pan-Ngum; Wang Yi; Hannah Clapham; Yot Teerawattananon
Journal:  Appl Health Econ Health Policy       Date:  2021-07-08       Impact factor: 2.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.